Chengzhi Zhang, Ph. D.

Chengzhi Zhang, Ph.D. has extensive experience in the pharmaceutical industry. Chengzhi began their career in 1993 as a Postdoc at Columbia University. In 1995, they became a Principal Scientist at Ontogen Corp. Chengzhi then moved to Bayer Healthcare, Pharmaceuticals in 1999 as a Principal Scientist. In 2007, they were a Sr. Investigator at GNF. Chengzhi then joined Auspex Pharmaceuticals, Inc. in 2008 as Senior Director of Chemistry & Manufacturing. In 2015, they became Senior Director of CMC, Drug Product Development, Global R&D at Teva Pharmaceuticals. In 2018, they were Executive Vice President at Hinova Pharmaceuticals. Most recently, in 2020, they were Senior Vice President of Chemistry and Vice President of Chemistry at Design Therapeutics.

Chengzhi Zhang, Ph. D. obtained their Doctor of Philosophy (Ph.D.) in Organic Chemistry from the University of Alberta in 1992. Prior to that, they earned a Master's degree in Oganosilicon Polymer Chemistry from Shandong University and a Bachelor's degree in Chemistry from the same university.